The Annual General Meeting of BioArctic AB on May 9, 2019, adopted instructions regarding the appointment of the Nomination Committee. Pursuant to these instructions the company shall have a Nomination Committee comprising one representative for each of the three largest shareholders in terms of votes based on the share register received from Euroclear Sweden AB on the last banking day in September 2019, as well as the Chairman of the Board (convener).
The three largest shareholders are Demban AB, Ackelsta AB and Tredje AP-fonden, and together represent approximately 64 percent of the shares and approximately 85 percent of the votes.
The Nomination Committee has been appointed and comprises the following members:
- Margareta Öhrvall, appointed by Demban AB
- Claes Andersson, appointed by Ackelsta AB
- Gunnar Blix, appointed by Tredje AP-fonden
The Nomination Committee shall prepare proposals for the 2020 Annual General Meeting regarding the Chairman of the Meeting, the number of Board members, the fees to be paid to the Chairman of the Board and Board members, election of Board members and Board Chairman, remuneration to the auditor and election of the auditor and, if necessary, a proposal for changes in the instructions to the Nomination Committee. The Nomination Committee’s proposal will be provided in the Notice for the Annual General Meeting 2020 and on BioArctic’s website at www.bioarctic.com.
Shareholders wishing to submit a proposal to BioArctic’s Nomination Committee can do so by e-mail to: ir@bioarctic.se (label e-mails with ”Nomination Committee” in the subject line) or by letter addressed to: BioArctic AB, Att: Nomination Committee, Warfvinges väg 35, SE-112 51 Stockholm, Sweden. In order for proposals to be handled appropriately, they must be received no later than January 15, 2020.
The Annual General Meeting 2020 of BioArctic will be held on Thursday, May 7, 2020 at 5:00 p.m. (CET) in Stockholm. A request to have a matter dealt with at the meeting must be received by February 28, 2020 to be included in the Notice.